• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. ESCHERICHIA COLI AND STAPHYLOCOCCUS AUREUS: BAD NEWS AND GOOD NEWS FROM THE EUROPEAN ANTIMICROBIAL RESISTANCE SURVEILLANCE NETWORK (EAR

Giuseppe

Emeritus
ESCHERICHIA COLI AND STAPHYLOCOCCUS AUREUS: BAD NEWS AND GOOD NEWS FROM THE EUROPEAN ANTIMICROBIAL RESISTANCE SURVEILLANCE NETWORK (EARS-NET, FORMERLY EARSS), 2002 TO 2009 (Euro Surveill., abstract, edited)

[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]

Eurosurveillance, Volume 16, Issue 11, 17 March 2011

Surveillance and outbreak reports

ESCHERICHIA COLI AND STAPHYLOCOCCUS AUREUS: BAD NEWS AND GOOD NEWS FROM THE EUROPEAN ANTIMICROBIAL RESISTANCE SURVEILLANCE NETWORK (EARS-NET, FORMERLY EARSS), 2002 TO 2009

C Gagliotti 1, A Balode 2, F Baquero 3, J Degener 4, H Grundmann 5, D G?r 6, V Jarlier 7, G Kahlmeter 8, J Monen 5, D L Monnet 1, G M Rossolini 9, C Suetens 1, K Weist 1, O Heuer 1, the EARS-Net Participants (Disease Specific Contact Points for AMR) 10

1 European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
2 Paul Stradins Clinical University Hospital, Riga, Latvia
3 University Hospital Ram?n y Cajal, Madrid, Spain
4 University Medical Centre Groningen, Groningen, the Netherlands
5 National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
6 Hacettepe University School of Medicine, Ankara, Turkey
7 Piti?-Salp?tri?re Hospital, Paris Cedex 13, France
8 Central Hospital V?xj?, V?xj?, Sweden
9 University of Siena, Siena, Italy
10 EARS-Net participant are listed at the end of the article

Citation style for this article: Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, G?r D, Jarlier V, Kahlmeter G, Monen J, Monnet DL, Rossolini GM, Suetens C, Weist K, Heuer O, the EARS-Net Participants (Disease Specific Contact Points for AMR). Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16(11):pii=19819. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19819

Date of submission: 13 October 2010

Based on data collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) and the former EARSS, the present study describes the trends in antimicrobial susceptibility patterns and occurrence of invasive infections caused by Escherichia coli and Staphylococcus aureus in the period from 2002 to 2009. Antimicrobial susceptibility results from 198 laboratories in 22 European countries reporting continuously on these two microorganisms during the entire study period were included in the analysis. The number of bloodstream infections caused by E. coli increased remarkably by 71% during the study period, while bloodstream infections caused by S. aureus increased by 34%. At the same time, an alarming increase of antimicrobial resistance in E. coli was observed, whereas for S. aureus the proportion of meticillin resistant isolates decreased. The observed trend suggests an increasing burden of disease caused by E. coli. The reduction in the proportion of meticillin-resistant S. aureus and the lesser increase in S. aureus infections, compared with E. coli, may reflect the success of infection control measures at hospital level in several European countries.

-
------
 
Back
Top Bottom